Effects of Power Mobility on Young Children With Severe Motor Impairments
Study Identifier:
2480
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
EU CT Number:
N/A
Sponsor:
University of Oklahoma
Study Complete
Study Details
Medical Condition
- All Spinal Muscular Atrophies
Study Drug
Date
Nov 2008 - Dec 2012
Phase 1
Phase 2
Phase 3
Phase 4
Patient Requirements
Sex: Female & Male
Age: 14 - 30 Months
Requirements Information
Inclusion and Exclusion Criteria
Inclusion Criteria
- Inclusion Criteria:
- Must be between 14- and 30-months of age
- Must have clinical diagnosis of a motor impairment that prevents functional independent mobility
- Must have adequate vision and hearing to use power mobility device safely
- Must have cognitive abilities equivalent to a 12-month level or alertness and interest in the environment that suggests a trial of power mobility is warranted
Protocol Summary
The purpose this study is to determine the effects of power mobility on the development and function of young children of young children whose severe physical disabilities limit their exploratory behaviors and may unnecessarily restrict their cognitive, communication, and social-emotional development.
Trial Locations
Location
Status
Location
Department of Rehabilitation Sciences, Lee Mitchener Tolbert Center for Develompental Disabilities
Oklahoma City, Oklahoma, United States, 73117
Status
N/A
Contact Cure SMA
User Information
If you have general questions regarding clinical trials or would like to be added to the Cure SMA mailing list to receive communications regarding future registries, studies, or clinical trials in SMA, please fill out the form below. Fields marked with an asterisk (*) are mandatory.